Promising dawn in tumor microenvironment therapy:engineering oral bacteria

被引:0
|
作者
Zifei Wang [1 ]
Wansu Sun [2 ]
Ruixue Hua [1 ]
Yuanyin Wang [1 ]
Yang Li [3 ]
Hengguo Zhang [1 ]
机构
[1] Key Laboratory of Oral Diseases Research of Anhui Province,College & Hospital of Stomatology,Anhui Medical University
[2] Department of Stomatology,The First Affiliated Hospital of Anhui Medical University
[3] Department of Genetics,School of Life Science,Anhui Medical
关键词
D O I
暂无
中图分类号
R730 [一般性问题]; R78 [口腔科学];
学科分类号
1003 ;
摘要
Despite decades of research, cancer continues to be a major global health concern. The human mouth appears to be a multiplicity of local environments communicating with other organs and causing diseases via microbes. Nowadays, the role of oral microbes in the development and progression of cancer has received increasing scrutiny. At the same time, bioengineering technology and nanotechnology is growing rapidly, in which the physiological activities of natural bacteria are modified to improve the therapeutic efficiency of cancers. These engineered bacteria were transformed to achieve directed genetic reprogramming, selective functional reorganization and precise control. In contrast to endotoxins produced by typical genetically modified bacteria, oral flora exhibits favorable biosafety characteristics. To outline the current cognitions upon oral microbes, engineered microbes and human cancers,related literatures were searched and reviewed based on the PubMed database. We focused on a number of oral microbes and related mechanisms associated with the tumor microenvironment, which involve in cancer occurrence and development. Whether engineering oral bacteria can be a possible application of cancer therapy is worth consideration. A deeper understanding of the relationship between engineered oral bacteria and cancer therapy may enhance our knowledge of tumor pathogenesis thus providing new insights and strategies for cancer prevention and treatment.
引用
收藏
页码:208 / 224
页数:17
相关论文
共 50 条
  • [31] Targeted Therapy and Immunosuppression in the Tumor Microenvironment
    Allegrezza, Michael J.
    Conejo-Garcia, Jose R.
    TRENDS IN CANCER, 2017, 3 (01): : 19 - 27
  • [32] Targeting the Tumor Microenvironment for Cancer Therapy
    Sounni, Nor Eddine
    Noel, Agnes
    CLINICAL CHEMISTRY, 2013, 59 (01) : 85 - 93
  • [33] Tumor Microenvironment as Target in Cancer Therapy
    Reich, Reuven
    Supuran, Claudiu T.
    Breuer, Eli
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 269 - 284
  • [34] Tumor microenvironment and the response to anticancer therapy
    Brown, JM
    CANCER BIOLOGY & THERAPY, 2002, 1 (05) : 453 - 458
  • [35] Editorial: Tumor microenvironment and cancer therapy
    Xie, Yi
    Xie, Jindong
    Gupta, Pranav
    Chen, Zhe-Sheng
    Zheng, Shaoquan
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [36] Tumor Microenvironment and Differential Responses to Therapy
    Hirata, Eishu
    Sahai, Erik
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (07): : 1 - 14
  • [37] Targeting Tumor Microenvironment for Cancer Therapy
    Roma-Rodrigues, Catarina
    Mendes, Rita
    Baptista, Pedro V.
    Fernandes, Alexandra R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (04)
  • [38] Antifibrotic therapy to normalize the tumor microenvironment
    Anette Hauge
    Einar K. Rofstad
    Journal of Translational Medicine, 18
  • [39] Targeting tumor microenvironment in cancer therapy
    Singh, Shree Ram
    Rameshwar, Pranela
    Siegel, Peter
    CANCER LETTERS, 2016, 380 (01) : 203 - 204
  • [40] Antifibrotic therapy to normalize the tumor microenvironment
    Hauge, Anette
    Rofstad, Einar K.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)